allergic reaction, fatigue, diarrhea, hair loss, nail changes and anorexia. The approved dosing regimen for the management of prostate cancer with docetaxel is 75 mg per square metre of body ...

Docetaxel is a chemotherapy drug that is used ... neutropenia, allergic reaction, fluid retention, edema, dizziness, hair loss, diarrhea, cramping and dysphagia, compared with those who took ...

Reported adverse effects of docetaxel include hypersensitivity reactions (presenting as flushing, skin reactions, hypotension and bronchospasm), bone marrow suppression (neutropenia, thrombocytopenia, ...

Fluid retention and hypersensitivity reactions were infrequent and mild. The combination of docetaxel and cisplatin is effective and feasible in patients with metastatic urothelial cancer with a ...

This side effect led to treatment discontinuation in 16 of 21 responding patients after a median of five cycles and a median cumulative dose of docetaxel of 574 mg/m2. Our data suggest that docetaxel ...

4 patients with advanced non-small-cell lung cancer (NSCLC) treated with docetaxel developed life-threatening pneumonitis requiring mechanical ventilation. Docetaxel (30–60 mg m –2 ...